- Home
- About
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Bipolar Disorder
- Depression
- Pseudobulbar Affect (PBA)
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Supporting Organizations
Virtual Event – Agitation Associated With Alzheimer’s Dementia Disease State Education

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Virtual Event – Agitation Associated With Alzheimer’s Dementia Disease State Education
This is a Virtual Event for PsychU members in DC, Maryland, North Carolina, South Carolina, and Virginia.
In this presentation, topics of discussion are:
- Alzheimer’s disease is highly prevalent, under-diagnosed, and predicted to increase significantly in the coming decades due to an aging population
- Agitation is a common neuropsychiatric symptom of Alzheimer’s dementia and highly prevalent across patient settings and Alzheimer’s disease severities
- The Cohen-Mansfield Agitation Inventory (CMAI) measures the frequency of manifestations of a broad range of agitated behaviors

Chris Brodie, PhD (OPDC)
Medical Science Liaison

Justin Wimmer, PharmD
Medical Science Liaison
Speakers Chris Brodie, PhD and Justin Wimmer, PharmD are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)